AUA 2017 Bladder Cancer - Results from #21

Viewing 22-41 of 73 articles

AUA 2017: Outcomes of Urothelial Bladder Cancer Patients Who Had Previous Upper Tract Urothelial Disease

AUA 2017: Universal Point of Care Testing for Lynch Syndrome in Patients with Upper Tract Urothelial Carcinoma

AUA 2017: A Prospective, Multicenter, Randomized Trial of Open Versus Robotic Radical Cystectomy (RAZOR)

AUA 2017: Comparative Effectiveness of Trimodal Therapy Versus Radical Cystectomy for Localized Muscle-Invasive Urothelial Carcinoma of the Bladder

AUA 2017: Neoadjuvant Chemotherapy for Elderly Patients with Locally Advanced or Early Nodal Disease: Are We Doing Enough?

AUA 2017: Safety and Efficacy Gemcitabine-Cisplatin Split Dose as a Neoadjuvant Chemotherapy for Muscle Invasive Bladder Cancer

AUA 2017: Distribution of Lymph Node Metastasis in Upper Urinary Tract Urothelial Cancer, Sub-Analysis of JCOG1110A Study

AUA 2017: Efficacy of Chemotherapy Administration in Elderly Patients with Metastatic Upper Tract Urothelial Carcinoma After Radical Nephroureterectomy

AUA 2017: Effectiveness of Adjuvant Chemotherapy After Radical Nephroureterectomy for Locally Advanced and/or Positive Regional Lymph Node Upper Tract Urothelial Carcinoma

AUA 2017: Bladder Cancer Tumor Board

AUA 2017: E-Cigarette Smoke is potentially Bladder Carcinogenic- It Induces Tumorigenic DNA Adducts and Inhibits DNA Repair in Urothelial Cells

AUA 2017: State-of-the-Art Lecture: Immunotherapy for Bladder Cancer

AUA 2017: Clinical Destiny of Indeterminate Pulmonary Nodules in Patients Undergoing Radical Cystectomy for Urothelial Carcinoma of the Bladder

AUA 2017: Use of Adjuvant Chemotherapy In Patients With Advanced Bladder Cancer After Neoadjuvant Chemotherapy

AUA 2017: Dose Dense Mvac Prior To Radical Cystectomy: A Retrospective Multi-institutional Experience

AUA 2017: Genomic Differences Between “Primary” And “Secondary” Muscle Invasive Bladder Cancer: Implications For Neoadjuvant Chemotherapy

AUA 2017: Incompleteness Of The Transurethral Resection As A Predictor Of Adverse Pathological Features At The Time Of Radical Cystectomy: Implications For Neoadjuvant Chemotherapy Selection

AUA 2017: Panel Discussion - Clinical Bladder Cancer Quandaries: What to Do Today and in the Future?

AUA 2017:Non-Muscle Invasive Bladder Cancer Guidelines

AUA 2017: High Risk Non-Muscle Invasive Bladder Cancer

1
2
3
4